Growing community of inventors

Zurich, Switzerland

Reinhard Dummer

Average Co-Inventor Count = 4.80

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Reinhard DummerMarkus Haake (2 patents)Reinhard DummerJörg Wischhusen (2 patents)Reinhard DummerMatthias Mehling (2 patents)Reinhard DummerTina Schäfer (1 patent)Reinhard DummerMartina Selle (1 patent)Reinhard DummerDaniel Widmer (1 patent)Reinhard DummerMitchell Paul Levesque (1 patent)Reinhard DummerJorg Wischhusen (1 patent)Reinhard DummerMarkus Haake (1 patent)Reinhard DummerMitchell Paul Levesque (0 patent)Reinhard DummerMarkus Haake (0 patent)Reinhard DummerDaniel Widmer (0 patent)Reinhard DummerMarieke Ineke Geertje Raaijmakers (0 patent)Reinhard DummerMarieke Ineke Raaijmakers (1 patent)Reinhard DummerTina SCHÄFER (0 patent)Reinhard DummerReinhard Dummer (2 patents)Markus HaakeMarkus Haake (12 patents)Jörg WischhusenJörg Wischhusen (7 patents)Matthias MehlingMatthias Mehling (2 patents)Tina SchäferTina Schäfer (4 patents)Martina SelleMartina Selle (1 patent)Daniel WidmerDaniel Widmer (1 patent)Mitchell Paul LevesqueMitchell Paul Levesque (1 patent)Jorg WischhusenJorg Wischhusen (4 patents)Markus HaakeMarkus Haake (1 patent)Mitchell Paul LevesqueMitchell Paul Levesque (0 patent)Markus HaakeMarkus Haake (0 patent)Daniel WidmerDaniel Widmer (0 patent)Marieke Ineke Geertje RaaijmakersMarieke Ineke Geertje Raaijmakers (0 patent)Marieke Ineke RaaijmakersMarieke Ineke Raaijmakers (1 patent)Tina SCHÄFERTina SCHÄFER (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Julius-Maximilians-Universitat Wurzburg (2 from 42 patents)

2. Universität Zürich Prorektorat Mnw (3 patents)


2 patents:

1. 11464856 - Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

2. 11262360 - GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/14/2026
Loading…